{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:48:32Z","timestamp":1753890512604,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To develop and validate a rapid invasive candidiasis (IC)-predictive risk score in intensive care unit (ICU) patients by incorporating clinical risk factors and parameters of lymphocyte subtyping.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective cohort study of 1054 consecutive patients admitted to ICU was performed. We assessed the clinical characteristics and parameters of lymphocyte subtyping at the onset of clinical signs of infection and their potential influence on IC diagnosis. A risk score for early diagnosis of IC was developed and validated based on a logistic regression model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixty-nine patients (6.5%) had IC. Patients in the cohort (N=1054) were randomly divided into a development (n=703) or validation (n=351) cohorts. Multivariate logistic regression identified that CD8+ T-cell count \u2264143 cells\/mm<jats:sup>3<\/jats:sup>, receipt of high-dose corticosteroids (dose \u226550 mg prednisolone equivalent), receipt of carbapenem\/tigecycline, APACHE II score\u226515, (1,3)-\u03b2-D-glucan (BDG) positivity and emergency gastrointestinal\/hepatobiliary (GIT\/HPB) surgery were significantly related with IC. IC risk score was calculated using the following formula: CD8+ T-cell count \u2264143 cells\/mm<jats:sup>3<\/jats:sup> + receipt of high-dose corticosteroids + receipt of carbapenem\/tigecycline + APACHE II score \u226515 + BDG positivity + emergency GIT\/HPB surgery \u00d72. The risk scoring system had good discrimination and calibration with area under the receiver operating characteristic (AUROC) curve of 0.820 and 0.807, and a non-significant Hosmer-Lemeshow test P=0.356 and P=0.531 in the development and validation cohorts, respectively. We categorized patients into three groups according to risk score: low risk (0-2 points), moderate risk (3-4 points) and high risk (5-7 points). IC risk was highly and positively associated with risk score (Pearson contingency coefficient=0.852, P for trend=0.007). Candida score had a moderate predicting efficacy for early IC diagnosis. The AUROC of the risk score was significantly larger than that of Candida score (0.820 versus 0.711, Z=2.013, P=0.044).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The predictive scoring system, which used both clinical factors and CD8+ T cell count, served as a clinically useful predictive model for rapid IC diagnosis in this cohort of ICU patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trial Registration<\/jats:title><jats:p>chictr.org.cn, identifier ChiCTR-ROC-17010750.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2022.829066","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T05:47:46Z","timestamp":1651038466000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and Validation of a Risk Score for Predicting Invasive Candidiasis in Intensive Care Unit Patients by Incorporating Clinical Risk Factors and Lymphocyte Subtyping"],"prefix":"10.3389","volume":"12","author":[{"given":"Jiahui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","article-title":"Systemic Antifungal Therapy in Critically Ill Patients Without Invasive Fungal Infection*","volume":"40","author":"Azoulay","year":"2012","journal-title":"Crit. Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","article-title":"A Multicenter Multinational Study of Abdominal Candidiasis: Epidemiology, Outcomes and Predictors of Mortality","volume":"41","author":"Bassetti","year":"2015","journal-title":"Intensive Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/viru.26187","article-title":"Invasive Candidiasis as a Cause of Sepsis in the Critically Ill Patient","volume":"5","author":"Delaloye","year":"2014","journal-title":"Virulence"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s1473-3099(03)00801-6","article-title":"Epidemiology of Candida Species Infections in Critically Ill Non-Immunosuppressed Patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00134-014-3355-z","article-title":"Candida Colonization Index and Subsequent Infection in Critically Ill Surgical Patients: 20 Years Later","volume":"40","author":"Eggimann","year":"2014","journal-title":"Intensive Care Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/CCM.0000000000005047","article-title":"Expression of Exhaustion Markers on CD8+ T-Cell Patterns Predict Outcomes in Septic Patients Admitted to the ICU","volume":"49","author":"Guinault","year":"2021","journal-title":"Crit. Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/jac\/dkt083","article-title":"Invasive Candidiasis in Intensive Care Units in China: A Multicentre Prospective Observational Study","volume":"68","author":"Guo","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17030","article-title":"Development and Validation of a Risk Model for Identification of Non-Neutropenic, Critically Ill Adult Patients at High Risk of Invasive Candida Infection: The Fungal Infection Risk Evaluation (FIRE) Study","volume":"17","author":"Harrison","year":"2013","journal-title":"Health Technol. Assess."},{"key":"B10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-Analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \"Candida Score\" for Discriminating Between Candida Colonization and Invasive Candidiasis in Non-Neutropenic Critically Ill Patients: A Prospective Multicenter Study","volume":"37","author":"Le\u00f3n","year":"2009","journal-title":"Crit. Care Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00134-020-06240-x","article-title":"Invasive Candidiasis in Critical Care: Challenges and Future Directions","volume":"46","author":"Logan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.2169\/internalmedicine.50.6175","article-title":"Diagnosis of Invasive Fungal Disease Using Serum (1\u21923)-\u03b2-D-Glucan: A Bivariate Meta-Analysis","volume":"50","author":"Lu","year":"2011","journal-title":"Intern. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1128\/aac.00658-06","article-title":"Reactivity of (1\u2013>3)-Beta-D-Glucan Assay With Commonly Used Intravenous Antimicrobials","volume":"50","author":"Marty","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1128\/jcm.05267-11","article-title":"Diagnostic Accuracy of Serum 1,3-\u03b2-D-Glucan for Pneumocystis Jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/cid\/ciw610","article-title":"Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients","volume":"63","author":"Playford","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13054-020-2766-1","article-title":"Risk Factors for Candidemia: A Prospective Matched Case-Control Study","volume":"24","author":"Poissy","year":"2020","journal-title":"Crit. Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1186\/cc8110","article-title":"Candidemia on Presentation to the Hospital: Development and Validation of a Risk Score","volume":"13","author":"Shorr","year":"2009","journal-title":"Crit. Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","article-title":"T Cells From Patients With Candida Sepsis Display a Suppressive Immunophenotype","volume":"20","author":"Spec","year":"2016","journal-title":"Crit. Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1046\/j.1537-2995.2002.00162.x","article-title":"Positive (1\u2013>3)-Beta-D-Glucan in Blood Components and Release of (1\u2013>3)-Beta-D-Glucan From Depth-Type Membrane Filters for Blood Processing","volume":"42","author":"Usami","year":"2002","journal-title":"Transfusion"},{"key":"B24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijid.2018.10.028","article-title":"Prospective Evaluation of Lymphocyte Subtyping for the Diagnosis of Invasive Candidiasis in Non-Neutropenic Critically Ill Patients","volume":"78","author":"Zhang","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jmii.2021.03.021","article-title":"Impact of mTOR Signaling Pathway on CD8+ T Cell Immunity Through Eomesodermin in Response to Invasive Candidiasis","volume":"54","author":"Zhang","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.829066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T05:47:49Z","timestamp":1651038469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.829066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":25,"alternative-id":["10.3389\/fcimb.2022.829066"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.829066","relation":{},"ISSN":["2235-2988"],"issn-type":[{"type":"electronic","value":"2235-2988"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"article-number":"829066"}}